{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:52:25Z","timestamp":1789426345872,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["22-15-00266"],"award-info":[{"award-number":["22-15-00266"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10689-024-00420-0","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T12:06:19Z","timestamp":1725624379000},"page":"659-664","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Asymptomatic Bloom syndrome diagnosed by chance in a patient with breast cancer"],"prefix":"10.1007","volume":"23","author":[{"given":"Evgeny","family":"Suspitsin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darya","family":"Eliseyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Chiryaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeniya","family":"Belogubova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Aleksakhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6304-1609","authenticated-orcid":false,"given":"Anna","family":"Sokolenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeny","family":"Imyanitov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,6]]},"reference":[{"key":"420_CR1","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1002\/ijc.32492","volume":"145","author":"C Cybulski","year":"2019","unstructured":"Cybulski C, Klu\u017aniak W, Huzarski T, Woko\u0142orczyk D, Kashyap A, Rusak B et al (2019) The spectrum of mutations predisposing to familial breast cancer in Poland. Int J Cancer 145:3311\u20133320. https:\/\/doi.org\/10.1002\/ijc.32492","journal-title":"Int J Cancer"},{"key":"420_CR2","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1002\/ijc.26342","volume":"130","author":"AP Sokolenko","year":"2012","unstructured":"Sokolenko AP, Iyevleva AG, Preobrazhenskaya EV, Mitiushkina NV, Abysheva SN, Suspitsin EN et al (2012) High prevalence and breast cancer predisposing role of the BLM c.1642 C\u2009>\u2009T (Q548X) mutation in Russia. Int J Cancer 130:2867\u20132873. https:\/\/doi.org\/10.1002\/ijc.26342","journal-title":"Int J Cancer"},{"key":"420_CR3","volume-title":"Short protocols in Human Genetics: a compendium of methods from current protocols in Human Genetics","author":"NC Dracopoli","year":"2004","unstructured":"Dracopoli NC, Haines JL, Korf BR, Morton CC, Seidman CE, Rosenzweig A, Seidman JG, Smith DR (2004) Short protocols in Human Genetics: a compendium of methods from current protocols in Human Genetics. Wiley, Hoboken"},{"key":"420_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00280-021-04301-6","volume":"88","author":"AP Sokolenko","year":"2021","unstructured":"Sokolenko AP, Gorodnova TV, Bizin IV, Kuligina ES, Kotiv KB, Romanko AA et al (2021) Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients. Cancer Chemother Pharmacol 88:439\u2013450. https:\/\/doi.org\/10.1007\/s00280-021-04301-6","journal-title":"Cancer Chemother Pharmacol"},{"key":"420_CR5","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.gim.2022.03.008","volume":"24","author":"TA Sugra\u00f1es","year":"2022","unstructured":"Sugra\u00f1es TA, Flanagan M, Thomas C, Chang VY, Walsh M, Cunniff C (2022) Age of first cancer diagnosis and survival in Bloom syndrome. Genet Med 24:1476\u20131484. https:\/\/doi.org\/10.1016\/j.gim.2022.03.008","journal-title":"Genet Med"},{"key":"420_CR6","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1002\/ajmg.a.40374","volume":"176","author":"C Cunniff","year":"2018","unstructured":"Cunniff C, Djavid AR, Carrubba S, Cohen B, Ellis NA, Levy CF et al (2018) Health supervision for people with Bloom syndrome. Am J Med Genet A 176:1872\u20131881. https:\/\/doi.org\/10.1002\/ajmg.a.40374","journal-title":"Am J Med Genet A"},{"key":"420_CR7","doi-asserted-by":"publisher","first-page":"104293","DOI":"10.1016\/j.ejmg.2021.104293","volume":"64","author":"MHD Schoenaker","year":"2021","unstructured":"Schoenaker MHD, Takada S, van Deuren M, Dommering CJ, Henri\u00ebt SSV, Pico I et al (2021) Considerations for radiotherapy in Bloom Syndrome: a case series. Eur J Med Genet 64:104293. https:\/\/doi.org\/10.1016\/j.ejmg.2021.104293","journal-title":"Eur J Med Genet"},{"key":"420_CR8","unstructured":"Langer K, Cunniff CM, Kucine N (2006) Bloom Syndrome. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1398\/"},{"key":"420_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s10549-012-2288-x","volume":"136","author":"JL Blum","year":"2012","unstructured":"Blum JL, Barrios CH, Feldman N, Verma S, McKenna EF, Lee LF et al (2012) Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer. Breast Cancer Res Treat 136:777\u2013788. https:\/\/doi.org\/10.1007\/s10549-012-2288-x","journal-title":"Breast Cancer Res Treat"},{"key":"420_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/ijd.13009","volume":"55","author":"J Vojtkov\u00e1","year":"2016","unstructured":"Vojtkov\u00e1 J, \u010ciljakov\u00e1 M, Jese\u0148\u00e1k M, Mi\u0161ovicov\u00e1 N, B\u00e1nov\u010din P (2016) Bloom syndrome without typical sun-sensitive skin lesions in three Slovak siblings. Int J Dermatol 55:687\u2013690. https:\/\/doi.org\/10.1111\/ijd.13009","journal-title":"Int J Dermatol"},{"key":"420_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000454820","volume":"8","author":"EN Suspitsin","year":"2017","unstructured":"Suspitsin EN, Sibgatullina FI, Lyazina LV, Imyanitov EN (2017) First two cases of Bloom Syndrome in Russia: lack of skin manifestations in a BLM c.1642C\u2009>\u2009T (p.Q548X) homozygote as a likely cause of Underdiagnosis. Mol Syndromol 8:103\u2013106. https:\/\/doi.org\/10.1159\/000454820","journal-title":"Mol Syndromol"},{"key":"420_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejmg.2017.10.010","volume":"61","author":"A Bouman","year":"2018","unstructured":"Bouman A, van Koningsbruggen S, Karakullukcu MB, Schreuder WH, Lakeman P (2018) Bloom syndrome does not always present with sun-sensitive facial erythema. Eur J Med Genet 61:94\u201397. https:\/\/doi.org\/10.1016\/j.ejmg.2017.10.010","journal-title":"Eur J Med Genet"},{"key":"420_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000507006","volume":"11","author":"J Trizuljak","year":"2020","unstructured":"Trizuljak J, Petruchov\u00e1 T, Blah\u00e1kov\u00e1 I, Vrzalov\u00e1 Z, Ho\u0159\u00ednov\u00e1 V, Doubkov\u00e1 M et al (2020) Diagnosis of Bloom Syndrome in a patient with short stature, recurrence of malignant lymphoma, and Consanguineous Origin. Mol Syndromol 11:73\u201382. https:\/\/doi.org\/10.1159\/000507006","journal-title":"Mol Syndromol"},{"key":"420_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.24953\/turkjpediatr.1999.3206","volume":"41","author":"K Boduro\u011flu","year":"1999","unstructured":"Boduro\u011flu K, Tun\u00e7bilek E (1999) Two siblings with Bloom\u2019s syndrome exhibit different clinical features: possible effect of sex. Turk J Pediatr 41:107\u2013111","journal-title":"Turk J Pediatr"},{"key":"420_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2131\/jts.37.235","volume":"37","author":"A Tekcan","year":"2012","unstructured":"Tekcan A, Elbistan M, Ulusoy AN (2012) Sister chromatid exchanges in breast cancer patients who underwent chemotherapy. J Toxicol Sci 37:235\u2013243. https:\/\/doi.org\/10.2131\/jts.37.235","journal-title":"J Toxicol Sci"},{"key":"420_CR16","doi-asserted-by":"publisher","first-page":"e1002894","DOI":"10.1371\/journal.pgen.1002894","volume":"8","author":"ER Thompson","year":"2012","unstructured":"Thompson ER, Doyle MA, Ryland GL, Rowley SM, Choong DY, Tothill RW et al (2012) Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles. PLoS Genet 8:e1002894. https:\/\/doi.org\/10.1371\/journal.pgen.1002894","journal-title":"PLoS Genet"},{"key":"420_CR17","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL et al (2015) Gene panel sequencing and the prediction of breast cancer risk. N Engl J Med 372:2243\u20132257. https:\/\/doi.org\/10.1056\/NEJMsr1501341","journal-title":"N Engl J Med"},{"key":"420_CR18","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.jcf.2019.06.012","volume":"18","author":"B T\u00fcmmler","year":"2019","unstructured":"T\u00fcmmler B (2019) Mild cystic fibrosis in carriers of two nonsense mutations - a case of genetic compensation response? J Cyst Fibros 18:e51\u2013e52. https:\/\/doi.org\/10.1016\/j.jcf.2019.06.012","journal-title":"J Cyst Fibros"},{"key":"420_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/mus.22252","volume":"45","author":"J Gurgel-Giannetti","year":"2012","unstructured":"Gurgel-Giannetti J, Senkevics AS, Zilbersztajn-Gotlieb D, Yamamoto LU, Muniz VP, Pavanello RC et al (2012) Thomsen or Becker Myotonia? A novel autosomal recessive nonsense mutation in the CLCN1 gene associated with a mild phenotype. Muscle Nerve 45:279\u2013283. https:\/\/doi.org\/10.1002\/mus.22252","journal-title":"Muscle Nerve"},{"key":"420_CR20","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/brain\/awq083","volume":"133","author":"H Tajsharghi","year":"2010","unstructured":"Tajsharghi H, Hilton-Jones D, Raheem O, Saukkonen AM, Oldfors A, Udd B (2010) Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutations. Brain 133:1451\u20131459. https:\/\/doi.org\/10.1093\/brain\/awq083","journal-title":"Brain"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-024-00420-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-024-00420-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-024-00420-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T09:17:50Z","timestamp":1729934270000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-024-00420-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,6]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["420"],"URL":"https:\/\/doi.org\/10.1007\/s10689-024-00420-0","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,6]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was reviewed and approved by the local Ethics Committee of the N.N. Petrov Institute of Oncology, approval number [No. 20\/25 23.01.2020].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The patient provided written informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}